- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Butenafine Hydrochloride 1% B
Total 1548 results
-
Hanmi Pharmaceutical Company LimitedCompletedHypertension | HyperlipidemiaKorea, Republic of
-
Medical University of GrazRecruiting
-
Baylor College of MedicineCompletedHookworm Infection | Hookworm DiseaseGabon
-
NovartisCompletedRelapsing Multiple SclerosisGermany, Italy, Australia, Austria, Belgium, Canada, Czech Republic, Denmark, Finland, Greece, Hungary, Ireland, Netherlands, Norway, Poland, Portugal, Russian Federation, Slovakia, Spain, Sweden, Switzerland, Turkey, United Kingdom
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple SclerosisGermany
-
Novartis PharmaceuticalsCompletedMultiple SclerosisColombia, Panama, Peru, Brazil, Jordan, Malaysia, Mexico, Argentina
-
New York Medical CollegeRecruitingHodgkin Lymphoma | Non-hodgkin LymphomaUnited States
-
National Cancer Institute (NCI)Not yet recruiting
-
OPKO Health, Inc.Elan PharmaceuticalsTerminatedAlzheimer's DiseaseUnited States, Canada, Spain, United Kingdom
-
Tang-Du HospitalNot yet recruitingIntracerebral Hemorrhage
-
Novartis PharmaceuticalsRecruitingMultiple SclerosisDenmark, Spain, Switzerland, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Colombia, Cyprus, Czechia, Finland, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Lebanon, Mexico, Netherlands, Norway, Poland, ... and more
-
Novartis PharmaceuticalsCompleted
-
HTL-Strefa S.A.Medical University of LodzCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1Poland
-
National Institute of Allergy and Infectious Diseases...CompletedHIV Infections | TuberculosisUnited States
-
Jochen VehoffCompletedMultiple Sclerosis | Autonomic Nervous System DysfunctionSwitzerland
-
Rashid Latif Medical CollegeUnknown
-
Actavis Inc.Teva Pharmaceuticals USACompletedRosaceaUnited States
-
Thomas Jefferson UniversityVerastem, Inc.Active, not recruitingMetastatic Uveal MelanomaUnited States
-
Brien Holden VisionCompletedRefractive Error | PresbyopiaAustralia
-
Janssen Research & Development, LLCCompletedSchizophreniaUnited States, Belgium, Taiwan, Spain, Israel, Malaysia, South Africa, Korea, Republic of, Slovakia, Croatia, Bulgaria
-
Tianjin Medical University General HospitalCompletedStroke | Stroke, Acute | Cerebral Stroke | Ischemic Cerebrovascular Accident | Vascular AccidentChina
-
University of Southern CaliforniaCompletedMultiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedKidney TransplantationUnited States
-
Novartis PharmaceuticalsTerminatedRelapsing Remitting Multiple Sclerosis (RRMS)Germany, Spain, Australia, Israel, Switzerland, Italy, Austria, Greece, Hungary, Czech Republic, Finland
-
Abramson Cancer Center of the University of PennsylvaniaNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
Zhao gengliVifor PharmaCompletedIron Deficiency Anemia | Iron DeficiencyChina
-
Fred Hutchinson Cancer CenterPfizerCompletedAcute Myeloid LeukemiaUnited States
-
AstraZenecaParexelCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Human Genome Sciences Inc., a GSK CompanyGlaxoSmithKlineCompletedSystemic Lupus ErythematosusUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Novartis PharmaceuticalsCompletedRelapsing Forms of Multiple SclerosisGermany, South Africa, Italy, United States, Austria, Belgium, Czechia, Egypt, Hungary, Malaysia, Turkey, Spain, Australia, Canada, France, Israel, Netherlands, Switzerland, Greece, Korea, Republic of, Romania, Russian Federation, United... and more
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple Sclerosis RRMSGermany, Switzerland
-
Novartis PharmaceuticalsCompletedMultiple Sclerosis, Relapsing-RemittingFrance
-
NovartisCompletedMultiple SclerosisUnited States, Canada
-
NovartisMitsubishi Tanabe Pharma CorporationCompletedMultiple SclerosisJapan
-
NovartisCompleted
-
Human Genome Sciences Inc.GlaxoSmithKlineCompletedSystemic Lupus ErythematosusUnited States, Spain, Israel, Netherlands, Canada, Germany, Poland, Romania, Puerto Rico, Costa Rica, Belgium, Slovakia, United Kingdom, Mexico, Italy, Austria, Czech Republic, Sweden, France
-
University of EdinburghUmeå UniversityCompletedCoronary DiseaseSweden
-
Tyra Biosciences, IncRecruitingSolid Tumor | Intrahepatic Cholangiocarcinoma | Metastatic Cholangiocarcinoma | Locally Advanced CholangiocarcinomaUnited States
-
Washington University School of MedicineSt. Louis Children's HospitalRecruitingHemoglobinopathies | Metabolic Disorders | Hematologic, Immune, or Bone Marrow Disorders | Non-malignant DisordersUnited States, Canada
-
Jilin Provincial Tumor HospitalUnknown
-
National Cancer Institute (NCI)CompletedMetastatic Urethral Carcinoma | Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage III Ureter Cancer AJCC v7 | Stage III Urethral Cancer AJCC v7 | Stage IV Bladder Urothelial Carcinoma AJCC v7 | Stage IV Ureter Cancer AJCC v7 | Stage IV Urethral Cancer AJCC v7 | Ureter Urothelial Carcinoma and other conditionsUnited States, Canada
-
Shanghai Jiao Tong University School of MedicineUnknown
-
Novartis PharmaceuticalsRecruiting
-
NovartisCompletedRenal InsufficiencyRussian Federation
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple SclerosisGermany
-
Novartis PharmaceuticalsTerminatedPrimary Progressive Multiple SclerosisUnited States, Belgium, Poland, Germany, Hungary, Turkey, Spain, Australia, Canada, Czechia, Switzerland, United Kingdom, Netherlands, France, Italy, Denmark, Finland, Sweden